Paul Unger
Northwestern University · 7 works · 443 citations · h-index 3
Top works
- Phase III Trial Comparing a Defined Duration of Therapy Versus Continuous Therapy Followed by Second-Line Therapy in Advanced-Stage IIIB/IV Non-Small-Cell Lung Cancer
- Second‐line, low‐dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first‐line chemotherapy with carboplatin plus paclitaxel
- Second-line (SL) weekly paclitaxel (P) in patients (pts) with advanced non-small cell lung cancer (NSCLC) failing first-line (FL) carboplatin/paclitaxel (C/P)
- Phase I trial of intravenous carboplatin added to oral etoposide and oral cyclophosphamide for stage IV non-small cell lung cancer
- [Role of transesophageal echocardiography in the diagnosis of pulmonary embolism].
- [Emergency surgery in the management of sagittal maxillary fractures using trans-maxillary wire fixation].
- [Tomographic aspects of the temporomandibular joint (TMJ). Comparative study of 30 subjects with rheumatoid arthritis and 30 normal subjects].